Old Web
English
Sign In
Acemap
>
authorDetail
>
Tatiana I. Prokopenko
Tatiana I. Prokopenko
Medicine
Biosimilar
Cmax
Clinical endpoint
Pathology
3
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and safety of BCD-021, bevacizumab biosimilar candidate, compared to Avastin in patients.
2014
Journal of Clinical Oncology
Sergey Orlov
Olga Burdaeva
Marina Nechaeva
Mikhail V. Kopp
Bogdan Kotiv
Ludmila P. Sheveleva
Oleg Gladkov
Andrey V. Khorinko
Tatiana I. Prokopenko
Julia S. Shapovalova
Irina A. Jelvakova
Nadezhda Kovalenko
Daniil L. Stroyakovsky
A. Pecheniy
R. Ivanov
Olga Filon
Sergei Tjulandin
Show All
Source
Cite
Save
Citations (10)
Efficacy and safety of BCD-017, a novel pegylated filgrastim: Results of open-label controlled phase II study in patients with breast cancer receiving myelosuppressive chemotherapy.
2013
Journal of Clinical Oncology
Olga V. Salafet
Tatiana V. Chernovskaya
Ludmila P. Sheveleva
Andrey V. Khorinko
Tatiana I. Prokopenko
Marina Nechaeva
Olga Burdaeva
Marina Matrosova
Nadezhda Kovalenko
Elena G. Ovchinnikova
Irina Koroleva
R. Ivanov
Show All
Source
Cite
Save
Citations (6)
1